Today
+4.31%
5 Days
+1.41%
1 Month
+4.68%
6 Months
+37.24%
Year to Date
+37.66%
1 Year
+56.16%
• Rising bond yields and tightening measures widened net interest margins. • The bank plans to increase its equity stake in VPBank. • Annual revenue reached $39.34 billion with a net profit of $10.50 billion.
• BOJ monetary policy normalization expectations boost Sumitomo Mitsui Financial Group shares. • Solid quarterly earnings and capital optimization efforts reinforce institutional investor confidence. • SMFG reports annual revenue of $39.34B and net profit of $10.50B.
• Sumitomo Mitsui fell amid broad Japanese equity and global market sell-offs. • Surging sovereign bond yields raised concerns over unrealized fixed-income losses. • The company reported an annual revenue of $39.34 billion.
• BOJ normalization expectations and rising interest rates benefit Sumitomo Mitsui Financial Group. • First-quarter earnings showed substantial year-over-year profit growth driven by interest income gains. • Disciplined capital management and positive analyst sentiment continue supporting equity valuations.
• Bank of Japan policy normalization improves net interest margins and core profitability. • Strategic capital efficiency and increased shareholder returns attract institutional investor interest. • The company reports $39.34 billion in annual revenue within the banking industry.
• Bank of Japan rate hike caution pressured Sumitomo Mitsui Financial Group's lending outlook. • Yen appreciation and global macroeconomic concerns negatively impacted the company's valuation. • Institutional investors conducted tactical profit-taking and portfolio rebalancing following recent sector outperformance.


| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 0.19% |
| Parametric Portfolio Associates LLC | 0.18% |
| Goldman Sachs Asset Management, L.P. | 0.12% |
| Aperio Group, LLC | 0.11% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 1.33% |
| Investment Advisor/Hedge Fund | 0.33% |
| Research Firm | 0.12% |
| Hedge Fund | 0.09% |
Related Instruments